Riskpilot← Back to searchSign inGet full accessEPITHERAPEUTICS ApS
APSIn liquidationCVR 30523067Amerika Plads 37Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900Est. 20081 employees
Revenue 2021
DKK 72K
-118% vs 2020
EBITDA margin
100.0%
+118% vs 2020
Equity ratio
28.1%
Financial strength
Net profit 2021
DKK -21,1M
-596% vs 2020
| Revenue | DKK 72K | -118% |
| EBITDA | DKK 72K | +118% |
| Net profit | DKK -21,1M | -596% |
| Total assets | DKK 32,7M | +7% |
| Equity | DKK 9,2M | -70% |
| Employees | 1 | — |
Legal name
EPITHERAPEUTICS ApS
CVR number
30523067
Legal form
Anpartsselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
18. september 2008
Share capital
DKK 4.545.875
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Amerika Plads 37
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -11.929 | -20.667 | -28.616 | -38.726 | 447.992 | -636 | — | -198 | -398 | 72 |
| Staff expenses | -13.033 | -13.868 | -16.306 | -11.797 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -24.961 | -34.535 | -44.922 | -51.273 | 447.992 | -636 | — | -198 | -398 | 72 |
| Depreciation & amort. | -751 | -843 | -613 | -494 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -25.712 | -35.378 | -45.535 | -51.767 | 447.992 | -636 | — | -198 | -398 | 72 |
| Net financials | -2.184 | -335 | 76 | -29 | 7.761 | -39.885 | 0 | 305 | -1.308 | 854 |
| Profit before tax | -27.896 | -35.713 | -45.458 | -51.796 | 455.753 | -40.521 | — | 107 | -1.707 | 926 |
| Tax | -1.250 | -1.250 | -6.125 | -34.704 | 99.392 | -4.791 | -0 | -493 | 1.322 | 21.999 |
| Net profit | -26.646 | -34.463 | -39.333 | -17.092 | 356.361 | -35.729 | — | 600 | -3.029 | -21.074 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 17.296 | 28.758 | 65.936 | 46.611 | 396.194 | 32.151 | 0 | 33.462 | 30.642 | 32.713 |
| Equity | -9.126 | 15.701 | 55.980 | 39.703 | 396.063 | 31.957 | — | 33.308 | 30.279 | 9.206 |
| Long-term debt | 22.244 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.179 | 13.057 | 9.956 | 6.908 | 131 | 194 | 0 | 154 | 363 | 23.508 |
| Total debt | 26.423 | 13.057 | 9.956 | 6.908 | 131 | 194 | 0 | 154 | 363 | 23.508 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122021
Equity ratio
28.1%
This company
38.2%
Market median
-26% vs market
20122021
Return on equity
-228.9%
This company
18.4%
Market median
-1344% vs market
20122021
Net profit margin
-29245.4%
This company
8.1%
Market median
-361154% vs market
20122021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122021
Debt / equity
2.55×
This company
0.62×
Market median
-311% vs market
20122021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Unofficial title | Unofficial title | 2016 | — | — |
MB Management | Management | 2008 | — | — |
SC Management | Management | 2008 | — | — |
KH Founder | Founder | 2008 | — | — |
KA Founder | Founder | 2008 | — | — |
RL Management | Management | 2015 | — | — |
BA Management | Management | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2008 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novo Holdings A/S | Company | 25.0% | 25.0% | 2014 |
| Individual | 100.0% | 100.0% | 2016 | |
| Individual | 100.0% | 100.0% | 2016 | |
| Individual | 100.0% | 100.0% | 2015 | |
| Individual | 15.0% | 15.0% | 2014 | |
SEED CAPITAL DENMARK K/S | Company | 25.0% | 25.0% | 2014 |
LUNDBECKFOND INVEST A/S | Company | 15.0% | 15.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EPITHERAPEUTICS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Holst Laursen | Unofficial title | 0 companies |
| Martin Bonde | Management | 0 companies |
| Stephan Christgau | Management | 0 companies |
| Klaus Hansen | Founder | 0 companies |
| Karl Agger | Founder | 0 companies |
| Robin Lynn Washington | Management | 0 companies |
| Brett Alan Pletcher | Management | 0 companies |
| Jon Ingi Benediktsson | Board of Directors | 0 companies |
| Mette Kirstine Agger | Board of Directors | 0 companies |
| Peter Høngård Andersen | Chairman | 0 companies |
| Georges Gemayel | Chairman | 0 companies |
| Jesper Aagaard Christensen | Board of Directors | 0 companies |
| Christian Ellebæk Elling | Board of Directors | 0 companies |
| Carsten Schou | Board of Directors | 0 companies |
| Kapil Dhingra | Board of Directors | 0 companies |
| Ali Fattaey | Board of Directors | 0 companies |
| Jasper Marnix Bos | Board of Directors | 0 companies |
| Henrijette Elsebeth Richter | Board of Directors | 0 companies |
| Paul Andreas Compare Cloos | Board of Directors | 0 companies |
| Claus Juan Møller-San Pedro | Board of Directors | 0 companies |
| Søren Møller | Board of Directors | 0 companies |
| Kristian Helin | Board of Directors | 0 companies |